Revive Therapeutics Ltd.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RVVTF research report →
About the company
Revive Therapeutics Ltd. , a life sciences firm founded in 2012 and headquartered in Toronto, Canada, is focused on discovering and advancing treatments for uncommon diseases and infectious illnesses. The company maintains a pharmaceutical pipeline centered on cannabinoids, specifically targeting rare inflammatory conditions.
- CEO
- Michael Frank
- IPO
- 2015
- Employees
- 3
- HQ
- Toronto, ON, CA
Price Chart
- Market Cap
- $8.71M
- P/E
- -1.31
- P/S
- 0.00
- P/B
- -3.25
- EV/EBITDA
- -1.24
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 288.66%
- ROIC
- 33.44%
- Revenue
- $0 · 0.00%
- Net Income
- $-11,011,319 · -95.98%
- EPS
- $-0.03 · -102.70%
- Op Income
- $-1,648,714
- FCF YoY
- 76.67%
- 52W High
- $0.06
- 52W Low
- $0.01
- 50D MA
- $0.02
- 200D MA
- $0.02
- Beta
- -1.83
- Avg Volume
- 249.20K
Get TickerSpark's AI analysis on RVVTF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our RVVTF coverage
Recent articles, reports, and earnings notes.
No research on RVVTF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate RVVTF report →Similar companies
Peers in the same neighborhood.